Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
NMTC Stock Chart & Stats
$0.71
-$0.09(-8.05%)
At close: 4:00 PM EST
$0.71
-$0.09(-8.05%)
Day’s Range― - ―
52-Week Range$0.40 - $1.25
Previous CloseN/A
Volume212.44K
Average Volume (3M)532.45K
Market Cap
$39.35M
Enterprise Value$34.73M
Total Cash (Recent Filing)$6.57M
Total Debt (Recent Filing)$266.81K
Price to Earnings (P/E)―
Beta1.78
Next Earnings
Feb 17, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding50,431,587
10 Day Avg. Volume702,340
30 Day Avg. Volume532,447
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)5.04
Price to Sales (P/S)2.95
P/FCF Ratio-12.22
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue3.82
Enterprise Value/Gross Profit6.75
Enterprise Value/Ebitda-11.54
Forecast
1Y Price Target
$3.00Price Target Upside322.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercial Adoption And PartnershipGrowing physician adoption supported by a Zimmer Biomet partnership and an expanding team of trained sales representatives should accelerate market uptake.
Regulatory And Clinical ExpansionFDA-cleared electrode platform and successful OneRF treatment in trigeminal neuralgia indicate regulatory validation and extension of clinical applications beyond epilepsy.
Technology And Clinical BenefitsMinimally invasive, high-definition electrodes can reduce brain trauma, enable less invasive implantation, and deliver more precise, higher-resolution recordings for diagnosis and therapy.
Bears Say
Financing And Dilution RiskNeed for extra financing to cover larger losses may lead to equity issuance or other dilutive measures that could weigh on shareholder value.
Liquidity And Cash BurnRising operating costs raise cash burn and could strain liquidity, potentially requiring the company to secure additional capital sooner than planned.
Operating Expenses And GAAP LossesHigher expected operating expenses have widened GAAP loss per share estimates for fiscal years 2026 and 2027, increasing pressure on reported profitability.
NeuroOne Medical Technologies News
NMTC FAQ
What was NeuroOne Medical Technologies’s price range in the past 12 months?
NeuroOne Medical Technologies lowest stock price was $0.40 and its highest was $1.25 in the past 12 months.
What is NeuroOne Medical Technologies’s market cap?
NeuroOne Medical Technologies’s market cap is $39.35M.
When is NeuroOne Medical Technologies’s upcoming earnings report date?
NeuroOne Medical Technologies’s upcoming earnings report date is Feb 17, 2026 which is in 7 days.
How were NeuroOne Medical Technologies’s earnings last quarter?
NeuroOne Medical Technologies released its earnings results on Dec 17, 2025. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of -$0.04 by -$0.01.
Is NeuroOne Medical Technologies overvalued?
According to Wall Street analysts NeuroOne Medical Technologies’s price is currently Undervalued.
Does NeuroOne Medical Technologies pay dividends?
NeuroOne Medical Technologies does not currently pay dividends.
What is NeuroOne Medical Technologies’s EPS estimate?
NeuroOne Medical Technologies’s EPS estimate is -0.04.
How many shares outstanding does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies has 50,431,587 shares outstanding.
What happened to NeuroOne Medical Technologies’s price movement after its last earnings report?
NeuroOne Medical Technologies reported an EPS of -$0.05 in its last earnings report, missing expectations of -$0.04. Following the earnings report the stock price went down -5.382%.
Which hedge fund is a major shareholder of NeuroOne Medical Technologies?
Currently, no hedge funds are holding shares in NMTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
NeuroOne Medical Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (322.54% Upside)
$3.00 (322.54% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.1%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.29%
12-Months-Change
Fundamentals
Return on Equity
-91.34%
Trailing 12-Months
Asset Growth
120.24%
Trailing 12-Months
Company Description
NeuroOne Medical Technologies
NeuroOne Medical Technologies (NMTC) is a medical device company focused on developing innovative solutions for neurological disorders, specifically targeting conditions such as epilepsy and chronic pain. The company operates within the healthcare sector, primarily specializing in advanced electrode technology and implantable devices designed for brain monitoring and stimulation. NMTC's core products include its ultra-thin and flexible electrode arrays, which are intended to improve the treatment outcomes for patients undergoing neurological procedures.
NMTC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including record product sales growth, improved gross margins, and successful FDA clearances. However, the company faces ongoing challenges with NASDAQ compliance and managing net losses. Overall, the positive aspects of growth and strategic developments outweigh the challenges.View all NMTC earnings summariesNMTC Stock 12 Month Forecast
Average Price Target
$3.00
▲(322.54% Upside)
Technical Analysis
Sensus Healthcare
―
Electrocore
―
Modular Medical
―
Vicarious Surgical
―
Inspira Technologies Oxy BHN
―
Ownership Overview
11.39% Insiders
3.22% Mutual Funds
0.17% Other Institutional Investors
82.67% Public Companies and
Individual Investors